Autopsy report · NCT05692908

An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amyloidosis

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Sorrento Therapeutics filed for chapter 11 bankruptcy.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: Sorrento Therapeutics, Inc.
Sponsor type: Industry
Conditions: Light Chain (AL) Amyloidosis
Interventions: STI-6129
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.